Seeing Is Believing
ORMP is currently covered by 2 analysts with an average price target of $11.68. This is a potential upside of $9.34 (399.15%) from yesterday's end of day stock price of $2.34.
Oramed Pharmaceuticals's activity chart (see below) currently has 15 price targets and 20 ratings on display. The stock rating distribution of ORMP is 40% BUY and 60% HOLD.
Analysts average stock forecasts to be materialized ratio is 55% with an average time for these price targets to be met of 125.75 days.
Highest price target for ORMP is $4, Lowest price target is $2, average price target is $11.68.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2024. First documented stock forecast 04-Dec-2013.
Currently out of the existing stock ratings of ORMP, 2 are a BUY (40%), 3 are a HOLD (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 months 5 days ago
(09-Sep-2024)
3/5 (60%)
$18.28 (133.24%)
278
Hold
$2
$-0.31 (-13.42%)
$3
1 years 5 months 28 days ago
(17-May-2023)
3/5 (60%)
$-1.63 (-44.90%)
157
Buy
$35
2 years 5 months 29 days ago
(16-May-2022)
1/2 (50%)
$9.92 (39.55%)
62
Buy
$40
$37.78 (1701.80%)
$11
3 years 5 days ago
(09-Nov-2021)
1/2 (50%)
$10.78 (36.89%)
6
What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?